BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 6623024)

  • 21. Germline SDHB mutations are common in patients with apparently sporadic sympathetic paragangliomas.
    Klein RD; Jin L; Rumilla K; Young WF; Lloyd RV
    Diagn Mol Pathol; 2008 Jun; 17(2):94-100. PubMed ID: 18382370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical management of hereditary pheochromocytoma.
    Yip L; Lee JE; Shapiro SE; Waguespack SG; Sherman SI; Hoff AO; Gagel RF; Arens JF; Evans DB
    J Am Coll Surg; 2004 Apr; 198(4):525-34; discussion 534-5. PubMed ID: 15051000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diagnosis and surgical treatment of extra-adrenal pheochromocytoma].
    Hiller WF; Scheumann GF; Dralle H
    Chirurg; 1993 Jan; 64(1):36-42. PubMed ID: 8436047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignancy in pheochromocytomas.
    Salmenkivi K; Heikkilä P; Haglund C; Arola J
    APMIS; 2004 Sep; 112(9):551-9. PubMed ID: 15601303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of pheochromocytoma management in the laparoscopic era.
    Solorzano CC; Lew JI; Wilhelm SM; Sumner W; Huang W; Wu W; Montano R; Sleeman D; Prinz RA
    Ann Surg Oncol; 2007 Oct; 14(10):3004-10. PubMed ID: 17690941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pheochromocytomas as adrenal gland incidentalomas].
    Cerović S; Cizmić M; Milović N; Ajdinović B; Brajusković G
    Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():47-51. PubMed ID: 12584998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of the insulin-like growth factor 1 receptor (IGF-1R) is associated with malignancy in familial pheochromocytomas and paragangliomas.
    Fernandez MC; Martin A; Venara M; Calcagno Mde L; Sansó G; Quintana S; Chemes HE; Barontini M; Pennisi PA
    Clin Endocrinol (Oxf); 2013 Nov; 79(5):623-30. PubMed ID: 23506534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncologic aspects of pheochromocytoma: the importance of follow-up.
    Scott HW; Halter SA
    Surgery; 1984 Dec; 96(6):1061-6. PubMed ID: 6505959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase 2 study of everolimus monotherapy in patients with nonfunctioning neuroendocrine tumors or pheochromocytomas/paragangliomas.
    Oh DY; Kim TW; Park YS; Shin SJ; Shin SH; Song EK; Lee HJ; Lee KW; Bang YJ
    Cancer; 2012 Dec; 118(24):6162-70. PubMed ID: 22736481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiolabeled DOTATOC in patients with advanced paraganglioma and pheochromocytoma.
    Forrer F; Riedweg I; Maecke HR; Mueller-Brand J
    Q J Nucl Med Mol Imaging; 2008 Dec; 52(4):334-40. PubMed ID: 18480742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tumors of the adrenal medulla and the paraganglia].
    Klöppel G
    Pathologe; 2003 Jul; 24(4):280-6. PubMed ID: 14513275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flow cytometric DNA analysis for the determination of malignant potential in adrenal and extra-adrenal pheochromocytomas or paragangliomas.
    Pang LC; Tsao KC
    Arch Pathol Lab Med; 1993 Nov; 117(11):1142-7. PubMed ID: 8239937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paragangliomas: clinical overview.
    Young WF
    Ann N Y Acad Sci; 2006 Aug; 1073():21-9. PubMed ID: 17102068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcome of a large series of patients surgically treated for pheochromocytoma.
    Khorram-Manesh A; Ahlman H; Nilsson O; Friberg P; Odén A; Stenström G; Hansson G; Stenquist O; Wängberg B; Tisell LE; Jansson S
    J Intern Med; 2005 Jul; 258(1):55-66. PubMed ID: 15953133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Global and regional CpG methylation in pheochromocytomas and abdominal paragangliomas: association to malignant behavior.
    Geli J; Kiss N; Karimi M; Lee JJ; Bäckdahl M; Ekström TJ; Larsson C
    Clin Cancer Res; 2008 May; 14(9):2551-9. PubMed ID: 18451216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinically unsuspected bilateral malignant pheochromocytoma.
    Powari M; Rajesh L; Joshi K
    Indian J Pathol Microbiol; 2007 Apr; 50(2):313-4. PubMed ID: 17883053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histopathology, cytology and cytochemistry of pheochromocytomas and paragangliomas including chemodectomas.
    Capella C; Riva C; Cornaggia M; Chiaravalli AM; Frigerio B; Solcia E
    Pathol Res Pract; 1988 Apr; 183(2):176-87. PubMed ID: 2838831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Functioning paraganglioma].
    Boneschi M; Erba M; Giuffrida GF; Mattioli A; Miani S
    Minerva Chir; 1993 Dec; 48(23-24):1399-405. PubMed ID: 8177442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative immunohistochemical study of phaeochromocytomas and paragangliomas.
    Fraga M; García-Caballero T; Antúnez J; Couce M; Beiras A; Forteza J
    Histol Histopathol; 1993 Jul; 8(3):429-36. PubMed ID: 8358154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Causes of recurrence of patients with chromaffin tumors].
    Bel'tsevich DG; Kuznetsov NS
    Khirurgiia (Mosk); 2002; (8):19-23. PubMed ID: 12389495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.